Innovent Biologics, Inc. (HKG:1801)

Innovent Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 3, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	66,183	69,333	51,403	70,547	115,098	33,521
Market Cap Growth	31.40%	34.88%	-27.14%	-38.71%	243.36%	20.57%
Enterprise Value	60,509	63,850	44,899	59,352	109,367	30,495
Last Close Price	40.40	42.75	33.50	48.25	82.05	26.55
PS Ratio	8.08	10.14	9.98	13.46	25.21	28.61
PB Ratio	4.93	5.02	4.24	5.56	11.04	6.30
P/TBV Ratio	4.88	5.03	4.25	5.57	11.04	6.30
P/OCF Ratio	100.48	425.78	-	-	-	-
EV/Sales Ratio	7.55	9.34	8.72	11.32	23.96	26.02
Debt / Equity Ratio	0.27	0.29	0.30	0.24	0.14	0.18
Asset Turnover	0.39	0.32	0.27	0.30	0.40	0.16
Inventory Turnover	2.13	1.51	1.00	1.19	1.45	2.94
Quick Ratio	2.42	2.68	2.78	3.27	5.85	4.78
Current Ratio	2.68	3.00	3.29	3.79	6.37	5.23
Return on Equity (ROE)	-11.04%	-8.84%	-20.70%	-28.56%	-14.75%	-38.43%
Return on Assets (ROA)	-4.18%	-5.12%	-11.54%	-12.03%	-3.65%	-17.05%
Return on Capital (ROIC)	-5.32%	-6.49%	-14.57%	-14.81%	-4.46%	-21.44%
Earnings Yield	-2.08%	-1.63%	-4.79%	-4.75%	-1.03%	-5.74%
FCF Yield	-1.08%	-1.54%	-6.19%	-5.38%	-0.82%	-6.78%
Buyback Yield / Dilution	-5.12%	-4.66%	-2.37%	-7.27%	-15.23%	-251.88%
Total Shareholder Return	-5.12%	-4.66%	-2.37%	-7.27%	-15.23%	-251.88%

Source: S&P Capital IQ. Standard template. Financial Sources.